Professor Adnan Tufail is an highly esteemed and experienced leading London-based ophthalmologist, who specialises in medical retina disorders and cataract surgery in the context of retinal diseases. He is the current clinical and research lead at the world-renowned Moorfields Eye Hospital for age-related macular degeneration (AMD).
His current areas of clinical research include novel drug and cell therapies for AMD, diabetic retinopathy and myopic degeneration, as well as a number of rare and complex retina disorders. To-date, Professor Tufail's professional medical career has been dominated by his dedicated treatment of retina blinding disorders. Professor Tufail is also well-regarded for his excellent work on complex and rare retinal disorders.
The highly revered Professor Tufail, who has been a consultant ophthalmologist at the London-based Moorfields Eye Hospital since 2003, has, impressively and deservedly, had his research recognised and awarded. Thanks to his excellent and constant contribution to eye research, he was awarded the position of professor at the highly established Institute of Ophthalmology, UCL (University College London). He was also voted as one of the top 10 most influential ophthalmologists in the world by his peers in 2018.
Professor Tufail has published extensively in clinical and scientific journals and is invited to lecture widely around the world. He has been engaged in clinical research trials which become a cornerstone for treatment protocols for a number of retinal disorders such as intravitreal injection therapy.